What one share of Fortress Biotech holds
Fortress Biotech, Inc. (“Fortress” or the “Company”) is a biopharmaceutical company focused on acquiring and advancing assets to enhance long-term value for shareholders through product revenue, equity holding and dividend and royalty revenue streams.
Fortress Biotech’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $2.15 |
|---|---|
| Profit | $3.25 |
| Cash and investments | $5.90 |
| Debt | $1.19 |
| Book value | $4.93 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2009 | — | −$15.15 | — | — | — | −$65.70 |
| 2010 | — | −$33.62 | — | — | — | −$49.77 |
| 2011 | — | −$82.65 | $0.00 | −$21.44 | — | — |
| 2012 | — | −$19.12 | $0.04 | −$16.10 | — | $13.54 |
| 2013 | $0.00 | −$18.32 | $0.02 | −$14.63 | — | $30.75 |
| 2014 | $0.00 | −$8.42 | $0.00 | −$6.75 | — | $22.75 |
| 2015 | $0.33 | −$18.56 | $0.11 | −$7.92 | — | $18.09 |
| 2016 | $6.19 | −$20.68 | $2.39 | −$19.59 | — | $11.80 |
| 2017 | — | −$24.08 | — | — | — | $15.46 |
| 2018 | $9.28 | −$29.04 | $2.44 | −$36.56 | — | $0.48 |
| 2019 | $10.04 | −$10.96 | $0.64 | −$26.68 | — | $5.31 |
| 2020 | $9.50 | −$9.69 | $0.40 | −$17.83 | — | $15.86 |
| 2021 | $12.63 | −$11.88 | $0.84 | −$22.23 | — | $16.07 |
| 2022 | $12.78 | −$15.97 | $0.46 | −$30.74 | — | $5.66 |
| 2023 | $10.42 | −$8.47 | $0.01 | −$15.82 | — | $1.49 |
| 2024 | $2.77 | −$2.69 | $0.00 | −$3.86 | — | $0.81 |
| 2025 | $2.27 | −$0.07 | — | — | — | $1.59 |
Common questions about Fortress Biotech
How much does one share of Fortress Biotech earn?
Over the last 12 months, each share of Fortress Biotech earned $3.25 of profit on $2.15 of sales, keeping about 151¢ of every $1 (profit margin).
Does Fortress Biotech pay a dividend?
Fortress Biotech didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Fortress Biotech’s book value per share?
Fortress Biotech’s book value is $4.93 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Fortress Biotech have?
Each share of Fortress Biotech has $5.90 of cash and investments and $1.19 of debt, as of June 30, 2026.
Has Fortress Biotech bought back shares?
Fortress Biotech’s share count rose about 11431% from 2009 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.